Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal Article (Journal Article)
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.
- Barth, M; Xavier, AC; Armenian, S; Audino, AN; Blazin, L; Bloom, D; Chung, J; Davies, K; Ding, H; Ford, JB; Galardy, PJ; Hanna, R; Hayashi, R; Lee-Miller, C; Machnitz, AJ; Maloney, KW; Marks, L; Martin, PL; McCall, D; Pacheco, M; Reilly, AF; Roshal, M; Song, S; Weinstein, J; Zarnegar-Lumley, S; McMillian, N; Schonfeld, R; Sundar, H
- November 2022
Volume / Issue
- 20 / 11
Start / End Page
- 1267 - 1275
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
- United States